DC Funds »

Tscan Therapeutics shares owned by DC Funds

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by DC Funds from 13F filings

Historical chart of DC Funds investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by DC Funds consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by DC Funds

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.7M 630k 5.85
2024-03-31 $5.0M 630k 7.94
2023-12-31 $3.7M 630k 5.83
2023-09-30 $1.6M 630k 2.56
2023-06-30 $1.6M 630k 2.50
2023-03-31 $1.3M 630k 2.10
2022-12-31 $977k 630k 1.55
2022-09-30 $1.9M 630k 3.05
2022-06-30 $2.0M 630k 3.14
2022-03-31 $1.8M 630k 2.80
2021-12-31 $2.8M 630k 4.50
2021-09-30 $5.3M 630k 8.34

More positions owned by DC Funds